Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Active (Oseltamivir)-Controlled Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Otherwise Healthy Pediatric Patients 1 to <12 Years of Age With Influenza-Like Symptoms
Conditions
Interventions
Baloxavir Marboxil
Oseltamivir
Locations
37
United States
Central Alabama Research; Pediatrics
Birmingham, Alabama, United States
Harrisburg Family Medical Center
Harrisburg, Arkansas, United States
The Children's Clinic of Jonesboro, P.A.
Jonesboro, Arkansas, United States
The Probe Medical Research
Los Angeles, California, United States
Orange County Research Institute
Ontario, California, United States
Khruz Biotechnology Research Institute
San Diego, California, United States
Start Date
November 20, 2018
Primary Completion Date
April 3, 2019
Completion Date
April 3, 2019
Last Updated
April 29, 2020
NCT01386424
NCT07291635
NCT06599658
NCT06094010
NCT06753474
NCT06417762
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions